A Cell-based Protein-protein Interaction Method Using a Permuted Luciferase Reporter
Overview
Authors
Affiliations
We have developed a novel cell-based protein-protein interaction assay method. The method relies on conversion of an inactive permuted luciferase containing a Tobacco Etch Virus protease (TEV) cleavage sequence fused onto protein (A) to an active luciferase upon interaction and cleavage by another protein (B) fused with the TEV protease. We demonstrate assay applicability for ligand-induced protein-protein interactions including G-protein coupled receptors, receptor tyrosine kinases and nuclear hormone receptors.
Kumar V, Lakshman P, Prasad T, Manjunath K, Bairy S, Vasu A Heliyon. 2024; 10(1):e23864.
PMID: 38226204 PMC: 10788520. DOI: 10.1016/j.heliyon.2023.e23864.
Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery.
Kongsamut S, Eishingdrelo H Drug Discov Today. 2023; 28(8):103641.
PMID: 37236523 PMC: 10524340. DOI: 10.1016/j.drudis.2023.103641.
Zhou G, Wan W, Wang W J Am Chem Soc. 2022; 144(50):22933-22940.
PMID: 36511757 PMC: 10026560. DOI: 10.1021/jacs.2c08280.
Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms.
Eishingdrelo H, Qin X, Yuan L, Kongsamut S, Yu L Curr Res Pharmacol Drug Discov. 2022; 3:100123.
PMID: 35992381 PMC: 9389249. DOI: 10.1016/j.crphar.2022.100123.
Current and future techniques for detecting oxytocin: Focusing on genetically-encoded GPCR sensors.
Lee D, Kwon H J Neurosci Methods. 2021; 366:109407.
PMID: 34763021 PMC: 11877391. DOI: 10.1016/j.jneumeth.2021.109407.